Preclinical development of a new peptide-based vaccine against human leishmaniasis

被引：0
|
作者：
Pissarra, J. [1 ]
Holzmuller, P. [2 ]
Bras-Goncalves, R. [1 ]
Garnaoui, A. [3 ]
Lemesre, J. -L. [1 ]
机构：
[1] IRD, UMR INTERTRYP, Montpellier, France
[2] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR CMAEE, Montpellier, France
[3] IPT, Lab Immunol Vaccinol & Genet Mol, Tunis, Tunisia
来源：
TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2017年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1S5.4
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [31] Towards a peptide-based vaccine against Shigella sonnei: A subtractive reverse vaccinology based approach
    Baseer, Shehneela
    Ahmad, Sajjad
    Ranaghan, Kara E.
    Azam, Syed Sikander
    BIOLOGICALS, 2017, 50 : 87 - 99
  • [32] Development of peptide-based inhibitors against ß-catenin using in silico approach
    Fujita, Minami
    Kikuchi, Amika
    Arita, Kyohei
    Misawa, Takashi
    Demizu, Yosuke
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [33] Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development
    Taiyu Liu
    Lu Li
    Cheng Cheng
    Bingfang He
    Tianyue Jiang
    Nano Research, 2022, 15 (8) : 7267 - 7285
  • [34] Preclinical and clinical experience with peptide-based vaccines against HPV16-induced tumors
    Melief, CJM
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1301 - 1301
  • [35] The application of self-assembled nanostructures in peptide-based subunit vaccine development
    Zhao, Guangzu
    Chandrudu, Saranya
    Skwarczynski, Mariusz
    Toth, Istvan
    EUROPEAN POLYMER JOURNAL, 2017, 93 : 670 - 681
  • [36] Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
    Focke-Tejkl, Margarete
    Weber, Milena
    Niespodziana, Katarzyna
    Neubauer, Angela
    Huber, Hans
    Henning, Rainer
    Stegfellner, Gottfried
    Maderegger, Bernhard
    Hauer, Martina
    Stolz, Frank
    Niederberger, Verena
    Marth, Katharina
    Eckl-Dorna, Julia
    Weiss, Richard
    Thalhamer, Josef
    Blatt, Katharina
    Valent, Peter
    Valenta, Rudolf
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (05) : 1207 - U614
  • [37] Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development
    Liu, Taiyu
    Li, Lu
    Cheng, Cheng
    He, Bingfang
    Jiang, Tianyue
    NANO RESEARCH, 2022, 15 (08) : 7267 - 7285
  • [38] Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development
    Berry, J. S.
    Vreeland, T. J.
    Hale, D. F.
    Jackson, D. O.
    Trappey, A. F.
    Greene, J. M.
    Hardin, M. O.
    Herbert, G. S.
    Clifton, G. T.
    Peoples, G. E.
    JOURNAL OF CANCER, 2017, 8 (07): : 1255 - 1262
  • [39] Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs
    de Aluja, AS
    Villalobos, NM
    Nava, G
    Toledo, A
    Martínez, JJ
    Plancarte, A
    Rodarte, LF
    Fragoso, G
    Sciutto, E
    VACCINE, 2005, 23 (31) : 4062 - 4069
  • [40] NOVEL PEPTIDE-BASED FPVA CONJUGATE VACCINE AGAINST PSEUDOMONAS AERUGINOSA RESPIRATORY INFECTIONS
    Sen, Kilic E.
    Blackwood, C. B.
    Bradford, S.
    Hall, J.
    Boehm, D.
    Varney, M.
    Wong, T.
    DeRoos, K.
    Bevere, J.
    Witt, W.
    Epperly, M.
    Damron, F.
    Barbier, M.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S351 - S351
12345